Correction to: Agonistic autoantibodies against adrenergic receptors correlating with antihypertensive therapy in long-standing diabetes type 2
- 76 Downloads
Correction to: Acta Diabetologica (2018) 55:301–303 https://doi.org/10.1007/s00592-018-1100-8
Unfortunately, the conflict of interest statement was found incomplete in the original publication and now revised by the authors. The updated version is provided here.
Conflict of interest
Investigations like patient recruitment, examination of patients, labor costs, statistics and writing manuscript were financed by house funds. The costs of determining the autoantibodies were carried by ERDE Diagnostics GmbH. Based on these results, we initiated a larger study, substantially financed by Fresenius Medical Care.